Mohammadreza Rostami, Maliheh Gharibshahian, Mehrnaz Mostafavi, Ali Sufali, Mahsa Golmohammadi, Mohammad Reza Barati, Reza Maleki, Nima Beheshtizadeh
{"title":"A supervised machine-learning analysis of doxorubicin-loaded electrospun nanofibers and their anticancer activity capabilities.","authors":"Mohammadreza Rostami, Maliheh Gharibshahian, Mehrnaz Mostafavi, Ali Sufali, Mahsa Golmohammadi, Mohammad Reza Barati, Reza Maleki, Nima Beheshtizadeh","doi":"10.3389/fbioe.2025.1493194","DOIUrl":null,"url":null,"abstract":"<p><p>Thanks to the diverse advantages of electrospun nanofibers, multiple drugs have been loaded in these nanoplatforms to be delivered healthily and effectively. Doxorubicin is a drug used in chemotherapy, and its various delivery and efficacy parameters encounter challenges, leading to the seeking of novel delivery methods. Researchers have conducted numerous laboratory investigations on the encapsulation of doxorubicin within nanofiber materials. This method encompasses various parameters for the production of fibers and drug loading, categorized into device-related, material-related, and study design parameters. This study employed a supervised machine-learning analysis to extract the influencing parameters of the input from quantitative data for doxorubicin-loaded electrospun nanofibers. The study also determined the significance coefficient of each parameter that influences the output results and identified the optimum points and intervals for each parameter. Our Support Vector Machine (SVM) analysis findings showed that doxorubicin-loaded electrospun nanofibers could be optimized through employing a machine learning-based investigation on the polymer solution parameters (such as density, solvent, electrical conductivity, and concentration of polymer), electrospinning parameters (such as voltage, flow rate, and distance between the needle tip and collector), and our study parameters, i.e., drug release and anticancer activity, which affect the properties of the drug-loaded nanofibers, such as the average diameter of fiber, anticancer activity, drug release percentage, and encapsulation efficiency. Our findings indicated the importance of factors like distance, polymer density, and polymer concentration, respectively, in optimizing the fabrication of drug-loaded electrospun nanofibers. The smallest diameter, highest encapsulation efficiency, highest drug release percentage, and highest anticancer activity are obtained at a molecular weight between 80 and 474 kDa and a doxorubicin concentration of at least 3.182 wt% with the polymer density in the range of 1.2-1.52 g/cm<sup>3</sup>, polymer concentration of 6.618-9 wt%, and dielectric constant of solvent more than 30. Also, the optimal distance of 14-15 cm, the flow rate of 3.5-5 mL/h, and the voltage in the range of 20-25 kV result in the highest release rate, the highest encapsulation efficiency, and the lowest average diameter for fibers. Therefore, to achieve optimal conditions, these values should be considered. These findings open up new roads for future design and production of drug-loaded polymeric nanofibers with desirable properties and performances by machine learning methods.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1493194"},"PeriodicalIF":4.3000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11933076/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1493194","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Thanks to the diverse advantages of electrospun nanofibers, multiple drugs have been loaded in these nanoplatforms to be delivered healthily and effectively. Doxorubicin is a drug used in chemotherapy, and its various delivery and efficacy parameters encounter challenges, leading to the seeking of novel delivery methods. Researchers have conducted numerous laboratory investigations on the encapsulation of doxorubicin within nanofiber materials. This method encompasses various parameters for the production of fibers and drug loading, categorized into device-related, material-related, and study design parameters. This study employed a supervised machine-learning analysis to extract the influencing parameters of the input from quantitative data for doxorubicin-loaded electrospun nanofibers. The study also determined the significance coefficient of each parameter that influences the output results and identified the optimum points and intervals for each parameter. Our Support Vector Machine (SVM) analysis findings showed that doxorubicin-loaded electrospun nanofibers could be optimized through employing a machine learning-based investigation on the polymer solution parameters (such as density, solvent, electrical conductivity, and concentration of polymer), electrospinning parameters (such as voltage, flow rate, and distance between the needle tip and collector), and our study parameters, i.e., drug release and anticancer activity, which affect the properties of the drug-loaded nanofibers, such as the average diameter of fiber, anticancer activity, drug release percentage, and encapsulation efficiency. Our findings indicated the importance of factors like distance, polymer density, and polymer concentration, respectively, in optimizing the fabrication of drug-loaded electrospun nanofibers. The smallest diameter, highest encapsulation efficiency, highest drug release percentage, and highest anticancer activity are obtained at a molecular weight between 80 and 474 kDa and a doxorubicin concentration of at least 3.182 wt% with the polymer density in the range of 1.2-1.52 g/cm3, polymer concentration of 6.618-9 wt%, and dielectric constant of solvent more than 30. Also, the optimal distance of 14-15 cm, the flow rate of 3.5-5 mL/h, and the voltage in the range of 20-25 kV result in the highest release rate, the highest encapsulation efficiency, and the lowest average diameter for fibers. Therefore, to achieve optimal conditions, these values should be considered. These findings open up new roads for future design and production of drug-loaded polymeric nanofibers with desirable properties and performances by machine learning methods.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.